Status:
COMPLETED
Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
Lead Sponsor:
Dr. Nazanin Alavi
Collaborating Sponsors:
Online PsychoTherapy Clinic
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Generalized anxiety disorder (GAD) is an extremely prevalent and debilitating mental health disorder. Currently, the gold standard treatment for GAD is cognitive behavioural therapy (CBT) and/or pharm...
Detailed Description
Methodology Research Design. This study has been designed using a quasi-experimental design to allow patients the freedom to choose which treatment modality they would like to participate in. This res...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Have consistent and reliable access to the internet
- Be diagnosed with GAD according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) by a clinician
- Meet the criteria for GAD according to the GAD-7 Screener (GAD-7)
- Be competent to consent to participate
- Speak and read English
Exclusion
- \- Patients will be deemed ineligible for participation in the study if they are in acute distress.
Key Trial Info
Start Date :
April 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT04478526
Start Date
April 29 2020
End Date
May 1 2021
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu Hospital
Kingston, Ontario, Canada, K7L 5G3